Hutch News
Results per Page:
New study identifies genetic changes in patients who progress to esophageal cancer
Findings in precancerous Barrett’s esophagus a step toward improved screening, prevention
Finding metabolites relevant to esophageal adenocarcinoma
From the Vaughan Lab, Public Health Sciences Division
Good News at Fred Hutch
Dr. Brian Reid invited speaker at NCI Excellence in Molecular Diagnostics lecture series; Dr. Katherine Tarlock earns grant to pursue treatments for childhood cancer
New insights into cancer evolution help define screening window of opportunity
A new appreciation of the genetic changes that occur as precancerous cells turn malignant could help researchers design new screening strategies
On target to halt esophageal cancer
Aspirin, other nonsteroidal anti-inflammatory drugs significantly reduce esophageal-cancer risk in people with most aggressive form of Barrett's
Aspirin significantly reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
Study also identifies biomarkers that predict which patients are most likely to get cancer
Thwarting cancer's call
Barrett's esophagus team advances cutting-edge research, clinical care to curb cancer progression
A friend on the front line of fear
Christine Karlsen helps Barrett's esophagus patients by speaking from a place of personal understanding